Milford-based biotech company Waters Corp. will merge with Becton, Dickinson and Co.’s biosciences an diagnostic solutions ...

Lab equipment maker Waters Corp on Monday said it will buy a bioscience and diagnostics unit spun off from medtech provider ...

A deal for Becton Dickinson’s biosciences and diagnostic solutions unit puts Waters Corp. in a greater position to compete ...

Shares of Waters Corp. WAT advanced 2.06% to $287.46 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.06% to 6,309.62 and ...

Becton, Dickinson and Company is an attractive firm that just made a good deal. Click here to find out why BDX stock is a Buy ...

Shares of Waters Corp. slid 3.16% to $287.53 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.01% to 6,296.79 and Dow Jones ...

Waters Corp. is paying $17.5B to merger with the biosciences unit of BD, doubling addressable market to $40B. However, ...

Waters Corp. reported strong growth rates for FY21 and is expecting solid growth for FY22. See why I think WAT stock is not a good investment right now.

Waters Corp. engages in the provision of workflow solutions involving liquid chromatography, mass spectrometry, and thermal analysis. It operates through the Waters and TA (TA Instruments) segments.

Waters Corporation beat analysts’ revenue expectations by 3.9% last quarter, reporting revenues of $740.3 million, up 4% year on year. It was a very strong quarter for the company, ...

Scientific instruments company Waters Corporation (NYSE:WAT) will be reporting earnings tomorrow morning. Here’s what to look for. Waters Corporation beat analysts’ revenue expectations by 1.9 ...

Waters Corporation. Global leader pioneering innovation in chromatography, mass spectrometry and thermal analysis Waters Corporation, a global leader in analytical instruments and software, has ...